Invention Grant
- Patent Title: In vitro production of cholangiocytes
-
Application No.: US15738282Application Date: 2016-06-21
-
Publication No.: US11021686B2Publication Date: 2021-06-01
- Inventor: Ludovic Vallier , Fotios Sampaziotis , Nicholas Hannan
- Applicant: CAMBRIDGE ENTERPRISE LIMITED
- Applicant Address: GB Cambridge
- Assignee: CAMBRIDGE ENTERPRISE LIMITED
- Current Assignee: CAMBRIDGE ENTERPRISE LIMITED
- Current Assignee Address: GB Cambridge
- Agency: Bozicevic, Field & Francis LLP
- Agent Pamela J. Sherwood
- Priority: GB1510950 20150622
- International Application: PCT/GB2016/051853 WO 20160621
- International Announcement: WO2016/207621 WO 20161229
- Main IPC: C12N5/071
- IPC: C12N5/071 ; A61K35/413 ; G01N33/50 ; A61P1/16

Abstract:
This invention relates to the efficient generation of cholangiocyte progenitor (CP) cells. Foregut stem cells (FSCs) are cultured in a hepatic induction medium comprising bone morphogenetic protein (BMP) and a TGFβ signalling inhibitor to produce a population of hepatoblasts. The hepatoblasts are then cultured in a biliary induction medium comprising fibroblast growth factor (FGF), retinoic acid and a TGFβ ligand to produce a population of cholangiocyte progenitors (CPs). The cholangiocyte progenitors (CPs) may be matured into cholangiocyte-like cells (CLCs) that display functional properties of Common Bile Duct (CBD) cholangiocytes. Methods, kits, cell populations and uses of these cell populations are provided.
Public/Granted literature
- US20180187160A1 IN VITRO PRODUCTION OF CHOLANGIOCYTES Public/Granted day:2018-07-05
Information query